Following ablation for AF, GLP-1 agonist therapy is associated with decreased risk for AF recurrence in patients with type 2 diabetes. Glucagon-like peptide-1 receptor (GLP-1) agonist use is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback